Understanding the current status helps patients make informed decisions
Healthcare providers typically monitor hemoglobin A1c, fasting blood glucose, lipid panels, kidney function tests (creatinine, eGFR, UACR), and liver function tests to assess treatment efficacy and safety
Until more data is available, use in patients with recent heart attacks or severe heart failure should be approached cautiously under medical supervision
PMID: 91 MeierJ
Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial
For a long time, this medication was the only drug of its type, but in recent years, other GLP-1 agonists have been approved for both the treatment of diabetes and the treatment of obesity